Nikkei jumps tracking Nasdaq, Tokyo Electron shines


Warning: This material has been prepared by a third party company, Reuters, which is independent of Davy. Davy has not reviewed the material and accepts no responsibility for errors or omissions, or for the information or opinions contained therein. It does not constitute investment advice.

    TOKYO, Oct 14 (Reuters) - Japan's Nikkei share average rose
on Thursday, tracking the Nasdaq overnight, with gains led by
chip equipment maker Tokyo Electron  8035.T  and other
heavyweight technology stocks.
    The Nikkei share average  .N225  advanced 0.97% to 28,413.61
by 0156 GMT, and the broader Topix  .TOPX  edged up 0.3% at
   Overnight, the Nasdaq  .IXIC  and the S&P 500  .SPX  gained 
as the Federal Reserve signalled on Wednesday it could start
reducing its crisis-era support for the U.S. economy, which
raised confidence for an economic recovery.
     The yield on benchmark 10-year Treasury notes  US10YT=RR 
    "Markets remain conscious about U.S. interest rates because
the rates affect U.S. growth stocks, which influence Nikkei's
heavyweights," said Seiichi Suzuki, chief equity market analyst
at Tokai Tokyo Research Institute.    
    Tokyo Electron  8035.T  lifted the Nikkei the most by rising
4.9% and Advantest  6857.T , its peer, gained 3.13%. 
    Medical equipment makers Olympus  7733.T  and Terumo
 4543.T  rose 2.49% and 1.26%, respectively.  
    Casual restaurant shares rose on hopes of a reopening
economy, with Saizeriya  7581.T  surging 13.87% and Yoshinoya
Holdings  9861.T  jumping 10.19%. 
    Bucking the trend, Japanese medical devices maker PHC
Holdings  6523.T  fell more than 10% on its initial day of
trading, despite pricing the stock at the bottom of the
    Shippers  .ISHIP.T  and oil refiners  .IPETE.T  led declines
among the exchange's 33 industry sub indexes by falling 5.21%
and 2.42%, respectively. 

 (Reporting by Junko Fujita; Editing by Amy Caren Daniel)
 ((813-4563-2711,, Reuters;))

Warning: This content may be provided by regulated and unregulated entities and is not created, reviewed or endorsed by Davy. It is provided for general information purposes only and does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. Importantly, it does not constitute investment advice, as it does not contemplate the personal circumstances of any particular person or group of persons. Neither Davy nor the providers of the Third Party Content will be liable for any investment decision made based on the reliance on or use of such data, or any liability that may arise due to delays or interruptions in the delivery of the Third Party Content for any reason.